Exploratory trials, confirmatory observations: A new reasoning model in the era of patient-centered medicine

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Sacristn, José A ^a  

^a Clinical Research Department   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PATHWAY; CLINICAL TRIAL (TOPIC); DECISION MAKING; EMPIRICAL RESEARCH; EVIDENCE BASED MEDICINE; HUMAN; LOGIC; METHODOLOGY; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTILIZATION REVIEW;

CLINICAL TRIALS AS TOPIC; CRITICAL PATHWAYS; DECISION MAKING; EMPIRICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; LOGIC; PATIENT-CENTERED CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79955024489     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-57     Document Type: Review

References (47)

1. Evidence-based medicine: how to practice and teach EBM. DL Sackett WS Richardson W Rosenberg RB Haynes, New York: Churchill Livingstone 1997
2. Can randomized trials inform clinical decisions about individual patients? M Mant, Lancet 1999 353 743 6 10.1016/S0140-6736(98)09102-8 10073531
3. Twentieth century paradigms that threaten both scientific and human medicine in the twenty-first century. AR Feinstein, J Clin Epidemiol 1996 49 615 7 10.1016/0895-4356(96)00040-6 8656219 (Pubitemid 26202686)
4. Patient-centered care and preference-sensitive decision making. CC Keirns SD Goold, JAMA 2009 302 1805 6 10.1001/jama.2009.1550 19861674
5. Comparative effectiveness research: a report from the Institute of Medicine. HC Sox S Greenfield, Ann Intern Med 2009 151 203 5 19567618
6. Charting a path from comparative effectiveness funding to improved patient-centered health care. PH Conway C Clancy, JAMA 2010 303 985 6 10.1001/jama.2010.259 20215615
7. Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient. JP Ioannidis J Lau, J Clin Epidemiol 1998 51 709 11 10.1016/S0895-4356(98)00042-0 9743320 (Pubitemid 28404366)
8. Genomic advances and their impact on clinical trial design. SJ Mandrekar DJ Sargent, Genome Medicine 2009 1 69 10.1186/gm69 19638184
9. Problems in the "evidence" of "evidence-based medicine". AR Feinstein IR Horwitz, Am J Med 1997 103 529 35 10.1016/S0002-9343(97)00244-1 9428837
10. Explanatory and pragmatic attitudes in therapeutic trials. D Schwartz J Lellouch, J Chronic Dis 1967 20 637 48 10.1016/0021-9681(67)90041-0 4860352
11. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. SR Tunis DB Stryer CM Clancy, JAMA 2003 290 1624 32 10.1001/jama.290.12.1624 14506122 (Pubitemid 37430387)
12. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. BR Luce JM Kramer SN Goodman JT Connor S Tunis D Whicher S Schwartz, Ann Intern Med 2009 151 206 9 19567619
13. Trials: the next 50 years. Large scale randomized evidence of moderate benefits. R Peto, BMJ 1998 317 1170 1 9794846
14. Why do we need some large simple randomized trials. S Yusuf R Collins R Peto, Stat Med 1984 3 409 20 10.1002/sim.4780030421 6528136 (Pubitemid 15167913)
15. Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials. CD Mullins D Whicher ES Reese S Tunis, Pharmacoeconomics 2010 28 969 76 10.2165/11536160-000000000-00000 20831305
16. Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. L Hilbrich P Sleight, Eur Heart J 2006 27 2158 64 10.1093/eurheartj/ehl152 16870690 (Pubitemid 44412828)
17. Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment. S Greenfield R Kravitz N Duan SH Kaplan, Am J Med 2007 120 3 S9 17720359
18. Choosing a first line antidepressant: equal on average does not mean equal for everyone. G Simon, JAMA 2001 286 3003 4 10.1001/jama.286.23.3003 11743843 (Pubitemid 33140366)
19. If not evidence, then what? Or does medicine really need a base? RE Upshur, J Eval Clin Pract 2002 8 113 9 10.1046/j.1365-2753.2002.00356.x 12180359 (Pubitemid 34685883)
20. Truth survival in clinical research: an evidence-based requiem? T Poynard M Munteanu V Ratziu Y Benhamou V Di Martino J Taieb P Opolon, Ann Intern Med 2002 136 888 95 12069563 (Pubitemid 34625701)
21. Statistical in medicine: Reporting of subgroup analyses in clinical trials. R Wang SW Lagakos JH Ware DJ Hunter JM Drazen, N Engl J Med 2007 357 2189 94 10.1056/NEJMsr077003 18032770
22. Subgroup analysis in randomized controlled trials: importance, indications, and interpretation. PM Rothwell, Lancet 2005 365 76 86
23. Evaluating the efficiency of targeted designs for randomized clinical trials. R Simon A Maitournam, J Clin Oncol 2004 10 6759 63 (Pubitemid 39383023)
24. Heberden oration. Reflection on the controlled trial. AB Hill, Ann Rheum Dis 1966 25 107 13 5326437
25. Clinical case reporting in evidence-based medicine. M Jenicek, Oxford Butterworth-Heinemann 1999 117
26. In defense of case reports and case series. JP Vandenbroucke, Ann Intern Med 2001 134 330 4 11182844 (Pubitemid 32163956)
27. Anecdotes that provide definitive evidence. JK Aronson M Hauben, BMJ 2006 333 1267 9 10.1136/bmj.39036.666389.94 17170419 (Pubitemid 46032359)
28. Induction versus Popper. Substance versus semantics. S Greenland, Int J Epidemiol 1998 27 543 8 10.1093/ije/27.4.543 9758105 (Pubitemid 28431493)
29. Merriam-Webster Online Dictionary copyright 2011 by Merriam-Webster, Incorporated
30. Are RCTs the gold standard? N Carwright, Biosocieties 2007 2 11 20 10.1017/S1745855207005029
31. Evidence-based medicine and philosophy of science. RB Bluhm, J Eval Clin Pract 2010 16 363 4 10.1111/j.1365-2753.2010.01401.x 20367865
32. Harveian Oration. De testimonio: on the evidence for decisions about the use of therapeutic interventions. M Rawlins, Lancet 2008 372 2152 61 10.1016/S0140-6736(08)61930-3 19101391
33. Evidence from randomized controlled trials, meta-analyses, and subgroup analyses. JA Sacristan, JAMA 2010 303 1253 4 20371781
34. In defense of destructive criticism. P Skrabanek, Perspect Biol Med 1986 30 9 26
35. Reflections on the limitations to epidemiology. G Davey Smith, J Clin Epidemiol 2001 54 325 31 10.1016/S0895-4356(00)00334-6 11297881
36. Time to reform in the drug-development process. J Fricker, Lancet Oncol 2008 9 1125 6 10.1016/S1470-2045(08)70297-3 19054853
37. Clinical case reports: sources of boredom or valuable pieces of evidence? M Jenicek, Nat J India 2001 14 193 4
38. Clinical judgment revisited: the distraction of quantitative models. AR Feinstein, Ann Intern Med 1994 120 799 805 8147553 (Pubitemid 24125302)
39. The emerging role of electronic medical records in pharmacogenomics. RA Wilke H Xu JC Denny DM Roden RM Krauss RM Krauss CA McCarty RL Davis T Skaar J Lamba G Savova, Clin Pharmacol Ther 2011 89 379 86 10.1038/clpt.2010.260 21248726
40. Individualized medical decision making. Necessary, achievable, but not yet attainable. L Fraenkel TR Fried, Arch Intern Med 2010 170 566 9 10.1001/archinternmed.2010.8 20308644
41. Individual case studies in primary health care. BC Charlton, Fam Pract 1999 16 1 2 10.1093/fampra/16.1.1 10321387
42. Individual case studies in clinical research. BG Charlton, J Eval Clin Practice 1998 4 147 55 10.1111/j.1365-2753.1998.tb00081.x (Pubitemid 128656559)
43. Users' guides to the medical literature. XXV. Evidence-based medicine: principles for applying the users' guides to patient care. GH Guyatt RB Haynes RZ Jaeschke DJ Cook L Green CD Naylor MC Wilson WS Richardson, JAMA 2000 284 1290 6 10.1001/jama.284.10.1290 10979117
44. Using n-of-1 trials as a clinical tool to improve prescribing. J Nikles AM Clavarino CB Del Mar, Br J Gen Practice 2005 55 175 80 (Pubitemid 40361405)
45. General treatments versus personalized treatments. F Rodríguez- Artalejo V Ortn, Gest Clin Sanit 2003 5 87 8
46. Talking about treatment: the language of populations and the language of individuals. JF Steiner, Ann Intern Med 1999 130 618 22 10189345 (Pubitemid 29169398)
47. Medicine-based evidence. JA Sacristn, Med Clin 1999 112 Suppl 1 9 11